Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning

Trends in Pharmacological Sciences

Volumn 20, Issue 11, 1999, Pages 438-441

  Van Helden, Herman P M ^a   Bueters, Tjerk J H ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 6 N CYCLOPENTYLADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ATROPINE; DIAZEPAM; ORGANOPHOSPHATE INSECTICIDE; SOMAN;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; DRUG EFFECT; DRUG RECEPTOR BINDING; INTOXICATION; MARMOSET; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; REVIEW;

EID: 0032704252     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01395-4     Document Type: Short Survey

References (24)

1. Willems J.L.et al. Arch. Toxicol. 67:1993;79-84.
2. Dawson R.M. J. Appl. Toxicol. 14:1994;317-331.
3. Van Helden H.P.M., Busker R.W., Melchers B.P.C., Bruijnzeel P.L.B. Arch. Toxicol. 70:1996;779-786.
4. Lallement G.et al. Arch. Toxicol. 72:1998;84-92.
5. Shih T.M., McDonough J.H. Jr. J. Appl. Toxicol. 17:1997;255-264.
6. Worek F., Widmann R., Knopff O., Szinicz L. Arch. Toxicol. 72:1998;237-243.
7. Solberg Y., Belkin M. Trends Pharmacol. Sci. 18:1997;183-185.
8. Beal M.F. Ann. Neurol. 38:1995;357-366.
9. Lallement G.et al. NeuroReport. 5:1994;1113-1117.
10. Hamilton M.G., Lundy P.M. Arch. Toxicol. 63:1989;144-149.
11. Leurs R., Blandina P., Tedford C., Timmerman H. Trends Pharmacol. Sci. 19:1998;177-183.
12. Van Helden H.P.M., Groen B., Moor E., Westerink B.H.C., Bruijnzeel P.L.B. Drug Chem. Toxicol. 21:1998;171-181.
13. Schubert P., Ogata T., Marchini C., Ferroni S., Rudolphi K. Ann. New York Acad. Sci. 825:1997;1-10.
14. Satoh Y., Hirashima N., Tokumaru H., Kirino Y. Neurosci. Res. 29:1997;325-333.
15. Morton R.A., Davis C.H. J. Physiol. 502:1997;75-90.
16. Di Iorio P.et al. J. Neurochem. 67:1996;302-309.
17. Herrero I., Castro E., Miras-Portugal M.T., Sanchez-Prieto J. J. Neurochem. 67:1996;2346-2354.
18. Muzzolini A., Bregola G., Bianchi C., Beani L., Simonato M. Neurochem. Int. 31:1997;113-124.
19. Longo R., Zeng Y.C., Sagratella S. Neurosci. Lett. 200:1995;21-24.
20. MacGregor D.G., Graham D.I., Jones P.A., Stone T.W. Gen. Pharmacol. 31:1998;233-238.
21. Andersom J.J., Kuo S., Chase T.N. Neurosci. Lett. 176:1994;264-268.
22. Van der Wenden E.M.et al. J. Med. Chem. 41:1998;102-108.
23. Roelen H.et al. J. Med. Chem. 39:1996;1463-1471.
24. Van Schaick E.A., Tukker H.E., Roelen H.C., IJzerman A.P., Danhof M. Br. J. Pharmacol. 124:1998;607-618.